Revelation Biosciences, Inc. (REVB)
NASDAQ: REVB · Real-Time Price · USD
1.200
+0.010 (0.84%)
Apr 14, 2026, 12:56 PM EDT - Market open
Revelation Biosciences Market Cap
Revelation Biosciences has a market cap or net worth of $4.46 million as of April 14, 2026. Its market cap has increased by 78.69% in one year.
Market Cap
4.46M
Enterprise Value
-5.58M
1-Year Change
78.69%
Ranking
Category
Stock Price
$1.20
Market Cap Chart
Since November 17, 2020, Revelation Biosciences's market cap has decreased from $90.51M to $4.46M, a decrease of -95.07%. That is a compound annual growth rate of -42.69%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 13, 2026 | 4.43M | -6.56% |
| Dec 31, 2025 | 4.74M | 22.99% |
| Dec 31, 2024 | 3.85M | 22.21% |
| Dec 29, 2023 | 3.15M | -29.09% |
| Dec 30, 2022 | 4.45M | -93.24% |
| Dec 31, 2021 | 65.80M | -29.40% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Nov 17, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| 60 Degrees Pharmaceuticals | 5.12M |
| Galmed Pharmaceuticals | 4.98M |
| Jaguar Health | 4.87M |
| CollPlant Biotechnologies | 4.78M |
| Indaptus Therapeutics | 4.73M |
| Akari Therapeutics, | 4.53M |
| Pulmatrix | 4.35M |
| Ensysce Biosciences | 4.32M |